Sign inGet started

Whitaker Anne Clem

Insider CIK 1593283 · ICLR Director · OSUR Director, Director · SNTA President and CEO, Director · ALKS Director · MNK Director · CLBS Director · VRX EVP, Company Group Chairman, Director · CREE Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ALKS Alkermes plc. A Award deriv2026-10-072026-10-0917,998— $017,998SEC↗
ALKS Alkermes plc. A Award deriv2026-10-072026-10-097,239— $07,239SEC↗
ICLR ICON PLC S Sale2026-08-112026-08-12590$164.47 $97.0K958SEC↗
ICLR ICON PLC S Sale2026-08-112026-08-1267$165.51 $11.1K891SEC↗
ICLR ICON PLC S Sale2026-08-112026-08-1296$163.77 $15.7K1,548SEC↗
ICLR ICON PLC S Sale2026-08-112026-08-1288$162.72 $14.3K1,644SEC↗
ICLR ICON PLC S Sale2026-08-112026-08-1267$165.51 $11.1K891SEC↗
ICLR ICON PLC S Sale2026-08-112026-08-12590$164.47 $97.0K958SEC↗
ICLR ICON PLC S Sale2026-08-112026-08-1296$163.77 $15.7K1,548SEC↗
ICLR ICON PLC S Sale2026-08-112026-08-1288$162.72 $14.3K1,644SEC↗
ICLR ICON PLC M Exercise deriv2026-08-102026-08-121,732— $00SEC↗
ICLR ICON PLC A Award deriv2026-08-102026-08-121,324— $01,324SEC↗
ICLR ICON PLC M Exercise2026-08-102026-08-121,732— $01,732SEC↗
ICLR ICON PLC A Award deriv2026-08-102026-08-121,324— $01,324SEC↗
ICLR ICON PLC M Exercise deriv2026-08-102026-08-121,732— $00SEC↗
ICLR ICON PLC M Exercise2026-08-102026-08-121,732— —1,732SEC↗
OSUR ORASURE TECHNOLOGIES INC F Tax w/h2023-05-162023-05-172,323$5.30 $12.3K23,840SEC↗
OSUR ORASURE TECHNOLOGIES INC F Tax w/h2023-05-152023-05-174,400$5.62 $24.7K26,163SEC↗
OSUR ORASURE TECHNOLOGIES INC A Award2022-05-162022-05-1820,000$5.25 $105.0K30,563SEC↗
CLBS CALADRIUS BIOSCIENCES, INC A Award2022-01-102022-01-1265,430— $0182,635SEC↗
OSUR ORASURE TECHNOLOGIES INC A Award2021-11-082021-11-1010,563$9.94 $105.0K10,563SEC↗
CLBS CALADRIUS BIOSCIENCES, INC A Award2021-01-112021-01-1237,735— $0117,205SEC↗
MNKKQ Mallinckrodt plc S Sale2020-11-062020-11-1021,087$0.13 $2.7K0SEC↗
CREE CREE, INC. M Exercise deriv2020-11-052020-11-064,000— $00SEC↗
CREE CREE, INC. S Sale2020-11-052020-11-0625,248$67.87 $1.71M11,274SEC↗
CREE CREE, INC. M Exercise2020-11-052020-11-064,000$57.36 $229.4K40,522SEC↗
CREE CREE, INC. S Sale2020-11-052020-11-064,000$68.35 $273.4K36,522SEC↗
CLBS CALADRIUS BIOSCIENCES, INC A Award2020-11-012020-11-0379,470$1.51 $120.0K79,470SEC↗
CREE CREE, INC. A Award2020-09-012020-09-032,652— $036,522SEC↗
MNK Mallinckrodt plc F Tax w/h2020-05-132020-05-158,729$2.96 $25.8K21,087SEC↗
CREE CREE, INC. A Award2019-09-012019-09-043,217— $033,870SEC↗
MNK Mallinckrodt plc A Award2019-05-152019-05-1719,396— $029,816SEC↗
MNK Mallinckrodt plc F Tax w/h2019-05-152019-05-178,527$15.21 $129.7K10,420SEC↗
CREE CREE INC A Award2018-09-012018-09-053,566— $030,653SEC↗
MNK Mallinckrodt plc A Award2018-05-162018-05-1818,947— $018,947SEC↗
CREE CREE INC A Award2017-09-012017-09-067,033— $027,087SEC↗
VRX Valeant Pharmaceuticals In F Tax w/h2016-12-052016-12-076,505$18.00 $117.1K158,885SEC↗
VRX Valeant Pharmaceuticals In F Tax w/h2016-12-052016-12-206,012$18.00 $108.2K158,544SEC↗
CREE CREE INC A Award2016-09-012016-09-066,429— $020,054SEC↗
VRX Valeant Pharmaceuticals In F Tax w/h2016-08-022016-12-20834$23.54 $19.6K158,544SEC↗
VRX Valeant Pharmaceuticals In A Award2016-05-122016-05-1637,935— $0165,390SEC↗
CREE CREE INC S Sale2016-02-162016-02-18623$30.00 $18.7K13,625SEC↗
CREE CREE INC S Sale2015-09-032015-09-031,994$26.74 $53.3K14,248SEC↗
CREE CREE INC A Award2015-09-012015-09-036,674— $016,242SEC↗
VRX Valeant Pharmaceuticals In A Award2015-07-202015-07-227,500— $0127,455SEC↗
VRX Valeant Pharmaceuticals In P Buy2015-05-262015-05-275,000$235.00 $1.18M5,000SEC↗
VRX Valeant Pharmaceuticals In P Buy2015-05-262015-05-272,500$234.00 $585.0K7,500SEC↗
VRX Valeant Pharmaceuticals In A Award2015-05-132015-06-24112,455— $0119,955SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award deriv2015-03-022015-03-04100,000— $0100,000SEC↗
CREE CREE INC S Sale2015-01-222015-01-23624$35.09 $21.9K9,568SEC↗
CREE CREE INC A Award2015-01-212015-01-23553$33.87 $18.7K10,192SEC↗
CREE CREE INC A Award2014-10-222015-01-23687$27.27 $18.7K9,639SEC↗
CREE CREE INC A Award2014-09-022014-10-244,244— $08,952SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award deriv2014-09-022014-09-04250,000— $0250,000SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award deriv2014-09-022014-09-04500,000— $0500,000SEC↗
CREE CREE INC A Award2014-09-022014-09-034,244— $08,952SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2014-09-022014-09-04500,000— $0500,000SEC↗
CREE CREE INC A Award2014-08-132014-08-15278$44.81 $12.5K4,708SEC↗
CREE CREE INC A Award2014-04-232014-04-25245$51.01 $12.5K4,430SEC↗
CREE CREE INC J Other2014-01-222014-01-24185$67.30 $12.5K4,185SEC↗
CREE CREE INC A Award deriv2013-12-022013-12-044,000— $04,000SEC↗
CREE CREE INC A Award2013-12-022013-12-044,000— $04,000SEC↗